Consistent with these observations, PPM1B significantly inhibited basal or shUSP12-upregulated NF-κB activity in tumour cells (Fig. 4f), and the USP12-mediated inhibition of chemokine expression was counteracted by PPM1B silencing (Fig. 4g). The gene discussed is NFKB1; the disease is neoplasm.